Pre-Filled Syringes West Coast 2021

SMi Group 14 - 15 June 2021, San Diego, USA.
Following the success of the last event, the Pre-Filled Syringes West Coast conference is back to uncover the latest innovations in combination product development, device design, human factors engineering and drug product formulation to give a holistic overview of the industry and what we can expect for the future.

With the global market for prefilled syringes estimated to exceed $9.7bn by 2025, this year's agenda will encompass key drivers and hot topics of the industry including; updates to regulatory guidance from industry experts and regulatory bodies, case studies on device design and complex formulation, life cycle and control strategies, and innovations in connectivity and digital health.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. PLUS, two interactive post conference workshops:

Workshop A: Connected devices and digital health: How to navigate the US FDA usability engineering requirements

Hosted by Shannon Clark, Principal, UserWise, Inc.

Workshop B: Postmarket safety reporting: The current regulatory environment with a global impact

Hosted by Khaudeja Bano, Sr. Medical Director, Abbott Molecular

Featured speakers

  • Brittney Pachucki, Device Engineer, AstraZeneca
  • Darin Zehrung, Global Program Leader, Medical Devices and Health Technologies, PATH
  • Jace Blackburn, Smart Device Engineer, Genentech
  • James P. Wabby, Executive Director, Regulatory Affairs - Device/Combination Products, Allergan
  • Jian Liu, Senior Scientist, Amgen
  • Khaudeja Bano, Senior, Medical Director, Abbott Diagnostics
  • Larry Atupem,  Sr Business Development Specialist, Zeon 
  • Maggie Reiff, Manager, Device Engineering, Pfizer
  • Mark DeStefano, Assoc. Dir. CPD Feasibility, New Technology and Prototyping Development, Teva Pharmaceuticals
  • Natalie Abts, Head of Human Factors Engineering, Genentech
  • Robert Ovadia, Engineer II, Genentech
  • Sarah Mollo, Combination Product Policy Analyst, FDA
  • Severine Duband, Global Category Manager, Nemera
  • Shannon Clark, Principal, UserWise, Inc.
  • Takuya Minezaki, Research Manager, Mitsubishi Gas Chemical Company, Inc.
  • Tina Rees, Associate Director - Human Factors, Ferring Pharmaceuticals
  • Tracy Hsu, Associate Director, Ionis Pharmaceuticals

Key reasons to attend

  • Engage in case study presentations from leading pharma and biotech companies on complex product formulation and optimising device design to aid delivery
  • Discuss show to optimise current processes to align with global regulatory updates
  • Delve into human factors engineering best practices
  • Uncover how industry is incorporating connectivity and digital health to optimise the user experience

Who should attend

Drug-delivery developers, Medical Device Engineers, Primary Packaging material designers, Secondary packagers, Smart device developers, Training device developers, Device-safety solution providers, Drug developers.

Early bird deadlines

  • Register by 31st March to save $200
  • Register by 30th April to save $100

For further information and to register, please visit:
http://www.prefilled-syringes-westcoast.com/wpnwl

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.

Most Popular Now

Sanofi and GSK sign agreements with the Government…

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. Thom...

Johnson & Johnson initiates pivotal global Pha…

Johnson & Johnson (NYSE: JNJ) (the Company) announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, J...

Scientists trace severe COVID-19 to faulty genes a…

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new resear...

Johns Hopkins researchers publish COVID-19 'predic…

Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers today...

Researchers uncover early results about an existin…

While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widesp...

Web resources bring new insight into COVID-19

Researchers around the world are a step closer to a better understanding of the intricacies of COVID-19 thanks to two new web resources developed by investigators at Bayl...

BioNTech and Pfizer initiate rolling submission to…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lea...

Boost for global response to COVID-19 as economies…

64 higher income economies have joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines rea...

COVID-19 vaccine AZD1222 clinical trial resumed in…

The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). ...

Vir Biotechnology and GSK announce global expansio…

Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Eff...

Johnson & Johnson announces European Commissio…

Johnson & Johnson (NYSE: JNJ) (the Company) announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Pur...

Adequate levels of vitamin D reduces complications…

Hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status), had a signif...